World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00729196
Date of registration: 05/08/2008
Prospective Registration: No
Primary sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Public title: A Trial of Two Diets for Weight and Diabetes Management Two-for-2
Scientific title: A Trial of Two Diets for Weight and Diabetes Management
Date of first enrolment: July 2005
Target sample size: 80
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00729196
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
United States
Contacts
Name:     Thomas A Wadden, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  University of Pennsylvania
Name:     Stanley Schwartz, M.D.
Address: 
Telephone:
Email:
Affiliation:  University of Pennsylvania
Name:     Virginia A Stallings, M.D.
Address: 
Telephone:
Email:
Affiliation:  Children's Hospital of Philadelphia
Name:     Anthony N Fabricatore, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  University of Pennsylvania
Key inclusion & exclusion criteria

Inclusion Criteria:

- Type 2 Diabetes Mellitus

- Body mass index (BMI) of 27 to 45 kg/m2 with weight
- Capacity to provide written informed consent

- Systolic blood pressure between 90 and 160 mm Hg, inclusive.

- Diastolic blood pressure between 65 and 100 mm Hg, inclusive.

- Resting heart rate between 65 and 90 beats per minute, inclusive.

Exclusion Criteria:

- a recent (i.e., within 1 year) myocardial infarction

- unstable angina

- malignant arrhythmias

- history of cerebrovascular, renal, or hepatic disease

- history of seizures

- protein wasting diseases (e.g., Cushing's syndrome)

- uncontrolled hypertension (> 160/100 mm Hg)

- type 1 diabetes

- uncontrolled thyroid disease

- pregnancy or lactation

- electrolyte abnormalities

- clinically significant psychosocial impairment (principally, major depression)

- treatment with steroids



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Type 2 Diabetes Mellitus
Obesity
Intervention(s)
Behavioral: Lifestyle Modification
Primary Outcome(s)
Percent change in weight [Time Frame: 92 weeks]
Secondary Outcome(s)
Change in HbA1c [Time Frame: 92 weeks]
Secondary ID(s)
K23 DK70777 (completed)
K23 DK070777
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Pennsylvania
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history